Open Access

MicroRNA‑135a‑5p is involved in osteoporosis progression through regulation of osteogenic differentiation by targeting RUNX2

  • Authors:
    • Xiaocong Shi
    • Zhen Zhang
  • View Affiliations

  • Published online on: August 5, 2019     https://doi.org/10.3892/etm.2019.7849
  • Pages: 2393-2400
  • Copyright: © Shi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A number of microRNAs (miRs) have been revealed to be involved in the development of osteoporosis, including postmenopausal osteoporosis. The aim of the present study was to investigate miR‑135a‑5p expression and the cellular function of miR‑135a‑5p and its underlying mechanism in postmenopausal osteoporosis. miR‑135a‑5p expression levels in the femoral neck trabecular bone tissue fragments from postmenopausal women with or without osteoporosis were detected by reverse transcription‑quantitative polymerase chain reaction and western blot analysis. The role of miR‑135a‑5p during osteogenic differentiation was examined by performing gain‑ and loss‑of‑function experiments using miR‑135a‑5p mimic or inhibitor. TargetScan bioinformatics analysis was sued to predict targets of miR‑135a‑5p, which were confirmed using luciferase reporter assays. miR‑135a‑5p expression was significantly upregulated in femoral neck trabecular bone tissue fragments from postmenopausal women with osteoporosis compared with postmenopausal women without osteoporosis. In addition, miR‑135a‑5p expression levels significantly decreased during osteogenic differentiation in the C2C12 cell model. miR‑135a‑5p overexpression decreased the osteogenic potential of C2C12 cells, as miR‑135a‑5p overexpression significantly reduced the expression levels of several key osteoblast markers, whilst miR‑135a‑5p knockdown had the opposite effect. Furthermore, the current study demonstrated that RUNX2 was a direct target of miR‑135a‑5p. Rescue experiments indicated that RUNX2 overexpression significantly reversed the effect of miR‑135a‑5p mimic on the osteogenic potential of C2C12 cells, indicating that miR‑135a‑5p mediates osteogenic differentiation via direct targeting of RUNX2. Taken together, these results suggest that miR‑135a‑5p may serve a role in osteoporosis progression by regulating osteogenic differentiation via RUNX2.

Related Articles

Journal Cover

October 2019
Volume 18 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Shi, X., & Shi, X. (2019). MicroRNA‑135a‑5p is involved in osteoporosis progression through regulation of osteogenic differentiation by targeting RUNX2. Experimental and Therapeutic Medicine, 18, 2393-2400. https://doi.org/10.3892/etm.2019.7849
MLA
Shi, X., Zhang, Z."MicroRNA‑135a‑5p is involved in osteoporosis progression through regulation of osteogenic differentiation by targeting RUNX2". Experimental and Therapeutic Medicine 18.4 (2019): 2393-2400.
Chicago
Shi, X., Zhang, Z."MicroRNA‑135a‑5p is involved in osteoporosis progression through regulation of osteogenic differentiation by targeting RUNX2". Experimental and Therapeutic Medicine 18, no. 4 (2019): 2393-2400. https://doi.org/10.3892/etm.2019.7849